Radiation therapy and medical technology innovation by Accuray

  • Andrey Mastykin
  • 21.07.2026
Accuray: 16 APBI treatments with helical TomoTherapy found feasible with low early toxicity in Taiwan study
Clinicians at Far Eastern Memorial Hospital in Taiwan conducted a retrospective analysis of 16 accelerated partial breast irradiation (APBI) treatment plans using helical TomoTherapy. The ...
  • Parshwa Turakhiya
  • 25.06.2026
AlignRT InBore integrates with Accuray Helical to support vendor-agnostic treatment advances
Accuray has announced the integration of AlignRT InBore with its Helical platform, aiming to advance flexible and vendor-agnostic solutions for modern treatment workflows. The company stated ...
  • Olga Shendetskaya
  • 18.06.2026
Accuray unveils innovative RT solutions at Lyon scientific conference
Accuray is participating live at Booth 8 during the 64th Journées Scientifiques de Physique Médicale in Lyon. The company is engaging with attendees to demonstrate its latest advances in ...
  • Mikhail Vnuchkov
  • 16.06.2026
Accuray to host webinar on Chiang Mai University TomoTherapy clinical data
Accuray announced a live webinar on June 25 to review 14 years of TomoTherapy clinical experience at Chiang Mai University with Dr. Nobnop. The session will be moderated by Lee Goddard and is ...
  • Andrey Mastykin
  • 03.06.2026
Accuray: CyberKnife radiosurgery halts progression in pituitary adenoma per Carlo Besta Institute study
Accuray reports that the Carlo Besta Neurological Institute has achieved disease stability in patients with non-functioning pituitary adenoma using multi-session radiosurgery with the CyberKnife ...
  • Ivan Andriyenko
  • 01.06.2026
CyberKnife treatment delivers full local control for uveal melanoma at ISRS2026, with favorable safety profile
Accuray reported that in a retrospective analysis presented at ISRS2026, all 68 uveal melanoma patients treated with CyberKnife achieved local tumor control at a mean follow-up of 46.5 months. ...
  • Artem Shendetskii
  • 29.05.2026
Accuray presents single day prostate radiotherapy approach at ESTRO26 with CyberKnife
Accuray has introduced a novel strategy for prostate cancer treatment, unveiling the PRO-FAST protocol at ESTRO26 in Milan. The approach utilizes single-day, single-fraction radiotherapy for ...
  • Mikhail Vnuchkov
  • 28.05.2026
Radixact platform draws attention to pediatric radiotherapy progress at ESTRO26
Accuray hosted a presentation at ESTRO26 featuring Dr Liam Herbert from Queen Elizabeth Hospital Birmingham, UK, highlighting developments in pediatric radiotherapy using the Radixact platform. ...